Skip to main content
. Author manuscript; available in PMC: 2009 Apr 8.
Published in final edited form as: Dev Neurobiol. 2008 Apr;68(5):632–644. doi: 10.1002/dneu.20609

Figure 3.

Figure 3

Histographs of SNpc DA neuronal survival following estrogen, IGF-1, PD98059 (MAPK/ERK inhibitor) and LY294002 (PI3K/Akt inhibitor) treatment. Timeline of treatments in Fig. 1(A). Values are mean percentage ± S.E.M of SNpc DA neuronal survival (lesion) ipsilateral vs. (control) contralateral intact side. Each value is calculated from 5 to 7 animals. * p < 0.05 compared to lesion, one-way ANOVA, Student Newman-Keuls posthoc.